The biotech company bought the genetic testing company for $256 million.

Regeneron Pharmaceuticals has agreed to acquire the assets of bankrupt genetic testing company 23andMe for $256 million. Regeneron pledged to "ensure compliance with 23andMe's consumer privacy ...

Salesforce Inc. will offer its Slack application to the federal government at a discounted rate, the latest software company ...

Dow Jones Top Company Headlines at 9 AM ET: Home Depot Plans to Keep Prices Steady Despite Tariffs | Honda ... The retailer has been pushing suppliers to shift production out of China and keep prices ...

Nippon Steel plans to invest $14 billion in U.S. Steel's operations including up to $4 billion in a new steel mill if the ...

The bankrupt genetic-testing firm will hand over its entire data bank, including DNA samples of around 15 million people. Regeneron has said it will abide by 23andMe’s privacy policy, allowing ...

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Share on Facebook Share on Twitter Jaelen Johnston continues to prove that it’s not how you start, it’s how you finish. On ...